No Data
No Data
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing With U.S.-Produced Synthetic DNA
Applied DNA Regains Compliance With Nasdaq Minimum Bid Price Requirement
Why Applied DNA Sciences (APDN) Stock Is Rising
Applied DNA Sciences Shares Are Trading Higher After the Company Announced It Positioned Its TR8 PGx Testing as Pre-emptive Testing for Therapeutic Safety.
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test